Department of Critical Care Medicine, The First Affiliated Hospital of Sun Yat-Sen University, No.58, Zhongshan 2nd Road, Yuexiu District, 510080, Guangzhou, Guangdong Province, China.
University of Exeter Medical School, University of Exeter, Heavitree Road, Exeter, EX12LU, Devon, UK.
Am J Surg. 2024 Nov;237:115790. doi: 10.1016/j.amjsurg.2024.115790. Epub 2024 May 31.
Despite the fact that red blood cell (RBC) transfusion is commonly applied in surgical intensive care unit (ICU), the effect of RBC transfusion on long-term outcomes remains undetermined. We aimed to explore the association between RBC transfusion and the long-term prognosis of surgical sepsis survivors.
This retrospective study was conducted on adult sepsis patients admitted to a tertiary surgical ICU center in China. Patients were divided into transfusion and non-transfusion groups based on the presence of RBC transfusion. Propensity score matching (PSM) and inverse probability of treatment weighting (IPTW)were performed to balance the potential confounders.
A total of 1421 surgical sepsis survivors were enrolled, including 403 transfused patients and 1018 non-transfused patients. There was a significant difference in 1-year mortality between the two groups (23.1 % vs 12.7 %, HR: 1.539, 95 % confidence interval [CI]: 1.030-2.299, P < 0.001). After PSM and IPTW, transfused patients still showed significantly increased 1-year mortality risks compared to non-transfused individuals (PSM: 23.6 % vs 15.9 %, HR 1.606, 95 % CI 1.036-2.488 P = 0.034; IPTW: 20.1 % vs 12.9 %, HR 1.600, 95 % CI 1.040-2.462 P = 0.032). Among patients with nadir hemoglobin below 70 g/L, 1-year mortality risks in both groups were similar (HR 1.461, 95 % CI 0.909-2.348, P = 0.118). However, among patients with nadir hemoglobin above 70 g/L, RBC transfusion was correlated with increased 1-year mortality risk (HR 1.556, 95 % CI 1.020-2.374, P = 0.040).
For surgical sepsis survivors, RBC transfusion during ICU stay was associated with increased 1-year mortality, especially when patients show hemoglobin levels above 70 g/L.
尽管红细胞(RBC)输血在外科重症监护病房(ICU)中被广泛应用,但输血对长期预后的影响仍不确定。我们旨在探讨 RBC 输血与外科脓毒症幸存者长期预后的关系。
本回顾性研究纳入了在中国一家三级外科 ICU 中心收治的成年脓毒症患者。根据是否进行 RBC 输血,将患者分为输血组和非输血组。采用倾向评分匹配(PSM)和逆概率处理加权(IPTW)来平衡潜在混杂因素。
共纳入 1421 例外科脓毒症幸存者,其中输血组 403 例,非输血组 1018 例。两组 1 年死亡率存在显著差异(23.1% vs 12.7%,HR:1.539,95%置信区间[CI]:1.030-2.299,P<0.001)。PSM 和 IPTW 后,输血组患者的 1 年死亡率仍显著高于非输血组(PSM:23.6% vs 15.9%,HR 1.606,95%CI:1.036-2.488,P=0.034;IPTW:20.1% vs 12.9%,HR 1.600,95%CI:1.040-2.462,P=0.032)。在血红蛋白最低值低于 70 g/L 的患者中,两组患者的 1 年死亡率相似(HR 1.461,95%CI:0.909-2.348,P=0.118)。然而,在血红蛋白最低值高于 70 g/L 的患者中,RBC 输血与 1 年死亡率升高相关(HR 1.556,95%CI:1.020-2.374,P=0.040)。
对于外科脓毒症幸存者,ICU 期间的 RBC 输血与 1 年死亡率增加相关,尤其是血红蛋白水平高于 70 g/L 时。